Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Tesamorelin - 5mg
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
$64.99
25 in stock (can be backordered)
Quantity | Quantity Discounts |
2 - 5 | $59.99 |
6 - 10 | $56.99 |
11 - 19 | $53.99 |
20 + | $49.99 |





- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
- Description
- Additional information
- Synonyms
- Appearance
- CAS #
- Structure
- Sequence
- Molecular Formula
- Molecular Weight
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.
Additional information
Weight | .291 g |
---|
Synonyms
Egrifta
Appearance
Lyophilized Powder
CAS #
901758-09-6
Structure
Sequence
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula
C221H366N72O67S
Molecular Weight
5136 g/mol
Reviews(1)
There are no reviews yet.